ProfileGDS4132 / 241692_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 36% 38% 33% 31% 41% 42% 35% 36% 37% 34% 40% 33% 36% 47% 30% 30% 36% 45% 30% 32% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10190.713436
GSM201543Muscle PCOS pioglitazone 12188.339738
GSM201544Muscle PCOS pioglitazone 16184.003833
GSM201545Muscle PCOS pioglitazone 20184.759431
GSM201829Muscle PCOS pioglitazone 231113.22941
GSM201830Muscle PCOS pioglitazon 251112.49342
GSM201831Muscle PCOS pioglitazone 27187.039235
GSM201832Muscle PCOS pioglitazone 3192.803236
GSM201833Muscle PCOS pioglitazone 4190.121937
GSM201834Muscle PCOS pioglitazone 8183.552634
GSM201835Muscle PCOS after pioglitazone 10287.8340
GSM201836Muscle PCOS after pioglitazone 12272.684833
GSM201837Muscle PCOS after pioglitazone 16277.557536
GSM201838Muscle PCOS after pioglitazone 202112.89347
GSM201839Muscle PCOS after pioglitazone 23267.891730
GSM201840Muscle PCOS after pioglitazone 25271.655930
GSM201841Muscle PCOS after pioglitazone 27277.249436
GSM201842Muscle PCOS after pioglitazone 3298.111245
GSM201843Muscle PCOS after pioglitazone 4273.070830
GSM201844Muscle PCOS after pioglitazone 8275.026532